SCHEMBL18626466

SCHEMBL18626466

CCOC(=O)[C@H](CCN(C)C)C[C@H](N)Cc1ccc(-c2cc(Cl)ccc2F)cc1

nearest known ligand 0.55

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ MME P08473 20/20 0.55
▸ ACE P12821 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18626459 0.92 MME (0.51) MMEACE
SCHEMBL16939296 0.90 MME (0.52) MMEACE
SCHEMBL18874713 0.89 MME (0.51) MMEACE
SCHEMBL16939330 0.89 MME (0.52) MMEACE
SCHEMBL16939261 0.88 MME (0.55) MMEACE
SCHEMBL20099595 0.88 MME (0.56) MMEACE
SCHEMBL18626436 0.87 MME (0.54) MMEACE
SCHEMBL16939334 0.87 MME (0.49) MMEACE
SCHEMBL18874867 0.87 MME (0.57) MMEACE
SCHEMBL20306310 0.86 MME (0.54) MMEACE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9593110-B2 Neprilysin inhibitors Theravence Biopharma R&D IP, LLC (US) 2017-03-14 — — US disclosed
Send feedback